ArisGlobal LifeSphere(R) MultiVigilance is selected by Asahi Kasei Pharma
PR92143
MIAMI and TOKYO, Oct. 6, 2021 /PRNewswire=KYODO JBN/ --
Asahi Kasei Pharma Corp. has selected LifeSphere(R) MultiVigilance
(https://c212.net/c/link/?t=0&l=en&o=3313917-1&h=479470560&u=https%3A%2F%2Fwww.arisglobal.com%2Fproducts%2Flifesphere-multivigilance%2F%3Futm_medium%3Dcpc%26utm_source%3Dadwords%26utm_campaign%3DSO-Brand%26gclid%3DCjwKCAjw_o-HBhAsEiwANqYhp9GtpStSttJBzyUNpLUWPVsgTKM6YnwZsNtfkIIwsHWPNSYsEnDvjBoC5XgQAvD_BwE&a=LifeSphere%C2%AE+MultiVigilance) as a new safety database with the purpose of building a system that supports efficiency, regulatory compliance, and global collaboration over the long term.
In addition, Asahi Kasei Pharma will adopt ArisGlobal's rapid migration
methodology, which has been successfully embraced by many of the world's
leading life sciences companies when transitioning from their legacy safety systems.
Logo - https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg
"We are very pleased that Asahi Kasei Pharma will adopt ArisGlobal's
multi-tenant LifeSphere(R) Safety suite," says Pat Jenakanandhini, Chief
Product Officer at ArisGlobal. "We offer the world's largest and most
innovative multi-tenant safety cloud. Asahi Kasei Pharma is an example of how
customers in Japan and globally can meet a wide range of requirements for
patient safety by leveraging our leading technology.
About ArisGlobal
ArisGlobal is transforming the way today's most successful Life Sciences
companies develop breakthroughs and bring new products to market. Our
end-to-end drug development technology platform, LifeSphere(R), integrates our
proprietary Nava(R) cognitive computing engine to automate all core functions
of the drug development lifecycle. Designed with deep expertise and a long-term
perspective that spans more than 30 years, LifeSphere(R) is a unified platform
that boosts efficiency, ensures compliance, delivers actionable insights, and
lowers total cost of ownership through multi-tenant SaaS architecture.
Headquartered in the United States, ArisGlobal has regional offices in Europe,
India, Japan, and China.
To learn more about ArisGlobal and its products, please visit the ArisGlobal
homepage. https://www.arisglobal.com/
About Asahi Kasei Pharma
In accordance with the Asahi Kasei Pharma Mission "To sincerely care for each
individual life and solve their unmet medical needs with a wealth of ideas and
solid science," Asahi Kasei Pharma operates pharmaceutical and diagnostic
businesses in the Health Care Business Unit of the Asahi Kasei Group. Asahi
Kasei Pharma has developed numerous innovative drugs in the field of
orthopedics, acute care, neurology (including pain), and immunology,
contributing to society by providing such products to patients who suffer from
diseases. For more information, please visit
https://www.asahikasei-pharma.co.jp/en/
SOURCE: ArisGlobal
CONTACT: Tiffany Murray, arisglobal@blastmedia.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。